Together with EU-collaborators, Eliava Institute has secured a grant under the HORIZON-WIDERA-2023-ACCESS-02 program.

The project, which will be led by Eliava Institute, will focus on phage therapy research and will enable knowledge transfer among the consortium members. Involved partners are INRAE (l’Institut national de recherche pour l’agriculture, l’alimentation et l’environnement) from France and University of Minho from Portugal. The project is foreseen to start in October 2024 and will go on for 36 months.